Home › NCT06666608

Bone Stimulator for Spondylolysis

The Efficacy of Bone Stimulator in Treatment and Return-to-Sport for Spondylolysis

Who can join

Ages 16 to 40 · All sexes

Inclusion Criteria:

* Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
* Patients who plan to attend prescribed physical therapy
* Patients who participate in a regular sport whether that be professional, collegiate or recreational

Exclusion Criteria:

* Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
* Patients with contraindications to bone stimulator therapy
* Patients with pacemaker and implantable cardioverter defibrillator
* Patients with previous spine surgery
* Patients with metabolic bone conditions
* Patients who use nicotine products
* Vulnerable populations
* Non-English speaking services

About the study

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

What is being tested

• Bone Stimulator (device)
• Standard of Care Spondylolysis Treatment (other)

Sponsor: The Methodist Hospital Research Institute · Participants: 48 · Started: Dec 3, 2025

Contact the study team

• Haley Goble, MHA · Phone: 713-441-3930

Official record on ClinicalTrials.gov — NCT06666608

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.